| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.29 | 6e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |